Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1557|24|3|223-227

ISSN： 1053-8569

Source： PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.3, 2015-03, pp. : 223-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein(a) and risk of myocardial infarction –– genetic epidemiologic evidence of causality

By Kamstrup Pia R.   Tybjæærg-Hansen Anne   Nordestgaard Bøørge G.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 71, Iss. 2, 2011-04 ,pp. : 87-93

Informa Healthcare

Access to resources Recommend Favorite

Geographical miss is associated with vulnerable plaque and increased major adverse cardiovascular events in patients with myocardial infarction

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 88, Iss. 3, 2016-09 ,pp. : 340-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Insulin resistance in non‐diabetic subjects is associated with increased incidence of myocardial infarction and death

By  

DIABETIC MEDICINE, Vol. 19, Iss. 6, 2002-06 ,pp. : 470-475

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral contraceptives and cardiovascular disease: emerging evidence on potential associations with angina, myocardial infarction and stroke

By Victory Rahi   Diamond Michael P  

Women's Health, Vol. 1, Iss. 1, 2005-07 ,pp. : 133-145

Future Medicine

Access to resources Recommend Favorite

Recognizing Increased Risk of Depressive Comorbidity after Myocardial Infarction: Looking for 4 Symptoms of Anxiety-Depression

By  

Psychotherapy and Psychosomatics, Vol. 75, Iss. 6, 2006-10 ,pp. : 346-352

Karger

Access to resources Recommend Favorite